ADMET Evaluation in Drug Discovery. 16. Predicting hERG Blockers by Combining Multiple Pharmacophores and Machine Learning Approaches.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Molecular Pharmaceutics

• Publication date

  2016-07-18

• Fields of study

  Chemistry, Medicine, Computer Science

• Identifiers
  DOI 10.1021/acs.molpharmaceut.6b00471PMID 27379394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Computational investigations of hERG channel blockers: New insights and current predictive models.

  2015cited by this paper
• In silico prediction of hERG inhibition.

  2015cited by this paper
• Combinatorial Pharmacophore Modeling of Multidrug and Toxin Extrusion Transporter 1 Inhibitors: a Theoretical Perspective for Understanding Multiple Inhibitory Mechanisms

  2015cited by this paper
• Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique.

  2015cited by this paper
• Experimentally Validated hERG Pharmacophore Models as Cardiotoxicity Prediction Tools

  2014cited by this paper
• Novel Bayesian classification models for predicting compounds blocking hERG potassium channels

  2014cited by this paper
• In Silico Prediction of Inhibition of Promiscuous Breast Cancer Resistance Protein (BCRP/ABCG2)

  2014cited by this paper
• Assessing hERG Pore Models As Templates for Drug Docking Using Published Experimental Constraints: The Inactivated State in the Context of Drug Block

  2014cited by this paper
• The Role of Balanced Training and Testing Data Sets for Binary Classifiers in Bioinformatics

  2013cited by this paper
• Combinatorial pharmacophore modeling of organic cation transporter 2 (OCT2) inhibitors: insights into multiple inhibitory mechanisms.

  2013cited by this paper
• Recent developments in computational prediction of HERG blockage.

  2013cited by this paper
• QSAR modeling and data mining link Torsades de Pointes risk to the interplay of extent of metabolism, active transport, and HERG liability.

  2012cited by this paper
• Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models.

  2012cited by this paper
• Predicting the potency of hERG K+ channel inhibition by combining 3D-QSAR pharmacophore and 2D-QSAR models

  2012cited by this paper
• Computational models for predicting substrates or inhibitors of P-glycoprotein.

  2012cited by this paper
• ADMET evaluation in drug discovery. 12. Development of binary classification models for prediction of hERG potassium channel blockage.

  2012cited by this paper
• Drug-likeness analysis of traditional Chinese medicines: prediction of drug-likeness using machine learning approaches.

  2012cited by this paper
• Prediction of Promiscuous P-Glycoprotein Inhibition Using a Novel Machine Learning Scheme

  2012cited by this paper
• hERG K(+) channels: structure, function, and clinical significance.

  2012cited by this paper
• PubChem's BioAssay Database

  2011cited by this paper
• LIBSVM: A library for support vector machines

  2011cited by this paper
• Combined Receptor and Ligand-Based Approach to the Universal Pharmacophore Model Development for Studies of Drug Blockade to the hERG1 Pore Domain

  2011cited by this paper
• ADME evaluation in drug discovery. 10. Predictions of P-glycoprotein inhibitors using recursive partitioning and naive Bayesian classification techniques.

  2011cited by this paper
• Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.

  2011cited by this paper
• Utility of protein structures in overcoming ADMET-related issues of drug-like compounds.

  2011cited by this paper
• The interactions between hERG potassium channel and blockers.

  2009cited by this paper
• Predicting drug resistance of the HIV‐1 protease using molecular interaction energy components

  2009cited by this paper
• Characterization of domain-peptide interaction interface: a case study on the amphiphysin-1 SH3 domain.

  2008cited by this paper
• The hERG K+ channel: target and antitarget strategies in drug development.

  2008cited by this paper
• Exploring QSTR and toxicophore of hERG K+ channel blockers using GFA and HypoGen techniques.

  2008cited by this paper
• hERG classification model based on a combination of support vector machine method and GRIND descriptors.

  2008cited by this paper
• Structure – ADME relationship: still a long way to go?

  2008cited by this paper
• The hERG potassium channel as a therapeutic target

  2007cited by this paper
• A quantitative assessment of hERG liability as a function of lipophilicity.

  2007cited by this paper
• A novel approach using pharmacophore ensemble/support vector machine (PhE/SVM) for prediction of hERG liability.

  2007cited by this paper
• ADME Evaluation in Drug Discovery, 8. The Prediction of Human Intestinal Absorption by a Support Vector Machine

  2007cited by this paper
• hERG potassium channels and cardiac arrhythmia

  2006cited by this paper
• An Accurate and Interpretable Bayesian Classification Model for Prediction of hERG Liability

  2006cited by this paper
• Recent advances in computational prediction of drug absorption and permeability in drug discovery.

  2006cited by this paper
• Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers.

  2006cited by this paper
• QT prolongation through hERG K+ channel blockade: Current knowledge and strategies for the early prediction during drug development

  2005cited by this paper
• Predictive in silico modeling for hERG channel blockers.

  2005cited by this paper
• Drugs, hERG and sudden death.

  2004cited by this paper
• HERG binding specificity and binding site structure: evidence from a fragment-based evolutionary computing SAR study.

  2004cited by this paper
• A model for identifying HERG K+ channel blockers.

  2004cited by this paper
• Sudden Death Associated With Short-QT Syndrome Linked to Mutations in HERG

  2003cited by this paper
• Three-dimensional quantitative structure-activity relationship for inhibition of human ether-a-go-go-related gene potassium channel.

  2002cited by this paper
• A Virtual Screening Method for Prediction of the hERG Potassium Channel Liability of Compound Libraries

  2002cited by this paper
• The inward rectification mechanism of the HERG cardiac potassium channel

  1996cited by this paper
• A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome.

  1995cited by this paper

• Integrating qHTS and QSAR Models to Identify Safe GPCR-Targeted Compounds: A Focus on hERG-Dependent Cardiotoxicity.

  2026cites this paper
• In vitro Enzyme Inhibition and Radical Scavenging Activity, and in silico Studies of Mespilus germanica L. (Rosaceae) Fruit Beverage (Fruit juice) and Molasses

  2026cites this paper
• Design and Evaluation of New 6-Trifluoromethoxy-Isatin Derivatives as Potential CDK2 Inhibitors.

  2026cites this paper
• Novel pyrimidine derivatives as promising antimycobacterial agents.

  2025cites this paper
• Update and ADMET Profile of the Latin American Natural Product Database: LANaPDB

  2025cites this paper
• hERG-LTN: A New Paradigm for hERG Cardiotoxicity Prediction Using Neuro-Symbolic and Generative AI

  2025cites this paper
• Computational toxicology in drug discovery: applications of artificial intelligence in ADMET and toxicity prediction

  2025cites this paper
• MTF-hERG: A Multi-Type Features Fusion-Based Framework for Predicting hERG Cardiotoxicity of Compounds

  2025cites this paper
• hERG-MFFGNN: An Explainable Deep Learning Model for Predicting Cardiotoxicity Using Multi-feature Fusion and Graph Neural Networks.

  2025cites this paper
• Recent advances in AI-based toxicity prediction for drug discovery

  2025cites this paper
• Multi-objective drug design with a scaffold-aware variational autoencoder

  2025cites this paper
• Pre-trained language models for protein and molecular design.

  2025cites this paper
• Breaking Bad Molecules: Are MLLMs Ready for Structure-Level Molecular Detoxification?

  2025cites this paper
• Leveraging Machine and Deep Learning Algorithms for hERG Blocker Prediction

  2025cites this paper
• Fleming: An AI Agent for Antibiotic Discovery in Mycobacterium tuberculosis

  2025cites this paper
• A Study on Neuro-Symbolic Artificial Intelligence: Healthcare Perspectives

  2025cites this paper
• An Integrated Fuzzy Neural Network and Topological Data Analysis for Molecular Graph Representation Learning and Property Forecasting

  2025cites this paper
• QCS-ADME: Quantum Circuit Search for Drug Property Prediction with Imbalanced Data and Regression Adaptation

  2025cites this paper
• Design and Synthesis of New 5-Methylisatin Derivatives as Potential CDK2 Inhibitors

  2025cites this paper
• SynthMol: A Drug Safety Prediction Framework Integrating Graph Attention and Molecular Descriptors into Pre-Trained Geometric Models

  2025cites this paper
• RAG-Enhanced Collaborative LLM Agents for Drug Discovery

  2025cites this paper
• hERG-LTN: A New Paradigm in hERG Cardiotoxicity Assessment Using Neuro-Symbolic and Generative AI Embedding (MegaMolBART, Llama3.2, Gemini, DeepSeek) Approach

  2025cites this paper
• MolFCL: predicting molecular properties through chemistry-guided contrastive and prompt learning

  2025cites this paper
• In silico Comparative Study of the Anti‐Cancer Potential of Inhibitors of Glucose‐6‐Phosphate Dehydrogenase Enzyme Using ADMET Analysis, Molecular Docking, and Molecular Dynamic Simulation

  2025cites this paper
• hERGAT: predicting hERG blockers using graph attention mechanism through atom- and molecule-level interaction analyses

  2025cites this paper
• SuperCardioTox: Drug-Induced Cardiotoxicity Prediction Based on Self-Supervised Learning

  2025influential citation
• Pyrimidine Derivative as Anti-Liver Cancer Agent against EGFR Kinase Mutant T790M/L858R: A Comprehensive In-silico Approach

  2025cites this paper
• MultiCBlo: Enhancing predictions of compound-induced inhibition of cardiac ion channels with advanced multimodal learning.

  2024cites this paper
• CardiOT: Towards Interpretable Drug Cardiotoxicity Prediction Using Optimal Transport and Kolmogorov--Arnold Networks

  2024cites this paper
• hERGBoost: A gradient boosting model for quantitative IC50 prediction of hERG channel blockers

  2024cites this paper
• Identification of metabolites from the gut microbiota in hypertension via network pharmacology and molecular docking

  2024influential citation
• In Silico Evaluation of Marine Phytochemicals as Potential Inhibitors of Inhibitor-Kappa B Protein Kinase (IκK) for Alzheimer’s Disease Therapeutics

  2024cites this paper
• Data-driven toxicity prediction in drug discovery: Current status and future directions.

  2024cites this paper
• Prediction of Drug‐Induced Liver Injury: From Molecular Physicochemical Properties and Scaffold Architectures to Machine Learning Approaches

  2024cites this paper
• Immunopotentiator of terpenoid from Hibiscus tiliaceus leaf fraction as candidate of vaccine adjuvants with in silico study

  2024cites this paper
• Machine learning and deep learning approaches for enhanced prediction of hERG blockade: a comprehensive QSAR modeling study

  2024cites this paper
• Multi-objective generative AI for designing novel brain-targeting small molecules

  2024cites this paper
• Advancements in Cardiotoxicity Detection and Assessment through Artificial Intelligence: A Comprehensive Review

  2024cites this paper
• The Goldilocks paradigm: comparing classical machine learning, large language models, and few-shot learning for drug discovery applications

  2024cites this paper
• Development of scoring-assisted generative exploration (SAGE) and its application to dual inhibitor design for acetylcholinesterase and monoamine oxidase B

  2024cites this paper
• GraphEGFR: Multi‐task and transfer learning based on molecular graph attention mechanism and fingerprints improving inhibitor bioactivity prediction for EGFR family proteins on data scarcity

  2024cites this paper
• Expanding Predictive Capacities in Toxicology: Insights from Hackathon-Enhanced Data and Model Aggregation

  2024cites this paper
• Bovine carbonic anhydrase (bCA) inhibitors: Synthesis, molecular docking and theoretical studies of bisoxadiazole-substituted sulfonamide derivatives.

  2024cites this paper
• Targeting human inosine 5’ monophosphate dehydrogenase type 2 for anti-dengue lead identification – a computational approach

  2024cites this paper
• Predicting Cardiotoxicity of Molecules Using Attention-Based Graph Neural Networks

  2024cites this paper
• Real-World Molecular Out-Of-Distribution: Specification and Investigation

  2024cites this paper
• Structural analysis of hERG channel blockers and the implications for drug design.

  2023cites this paper
• Identification of Spiro[chromene-2,4'-piperidine]s as Potent, Selective, and Gq-Biased 5-HT2C Receptor Partial Agonists.

  2023cites this paper
• ADMET and Solubility Analysis of New 5-Nitroisatine-Based Inhibitors of CDK2 Enzymes

  2023cites this paper
• Variational graph encoders: a surprisingly effective generalist algorithm for holistic computer-aided drug design

  2023cites this paper
• Application of variational graph encoders as an effective generalist algorithm in computer-aided drug design

  2023cites this paper
• On QSAR-based cardiotoxicity modeling with the expressiveness-enhanced graph learning model and dual-threshold scheme

  2023cites this paper
• Artificial Intelligence in Drug Toxicity Prediction: Recent Advances, Challenges, and Future Perspectives

  2023cites this paper
• Synthesis, DFT calculations, and anti-proliferative evaluation of pyrimidine and selenadiazolopyrimidine derivatives as dual Topoisomerase II and HSP90 inhibitors

  2023cites this paper
• Ensemble of structure and ligand-based classification models for hERG liability profiling

  2023cites this paper
• Synthesis, structure, in vitro pharmacology, and in vivo activity of trans‐3,4‐dichloro‐N‐[[1‐(dimethylamino)‐4‐phenylcyclohexyl]methyl]‐benzamide (AP01; 4‐phenyl‐AH‐7921), a novel mixed μ‐/κ‐opioid

  2023cites this paper
• In Silico study and design of some new potent threonine tyrosine kinase inhibitors using molecular docking simulation

  2023cites this paper
• Tachykinin/neurokinin 3 receptor antagonists: In silico ADME/T analysis of novel compounds for menopause hot flashes therapy

  2022cites this paper
• Advancing pharmacy and healthcare with virtual digital technologies.

  2022cites this paper
• Transfer inhibitory potency prediction to binary classification: A model only needs a small training set

  2022cites this paper
• Predicting hERG channel blockers with directed message passing neural networks

  2022cites this paper
• Breast cancer drug toxicity prediction Based on AdaBoost Extremely Random Tree

  2022cites this paper
• BayeshERG: a robust, reliable and interpretable deep learning model for predicting hERG channel blockers

  2022cites this paper
• hERG Blockade Prediction by Combining Site Identification by Ligand Competitive Saturation and Physicochemical Properties

  2022cites this paper
• Roughness of Molecular Property Landscapes and Its Impact on Modellability

  2022cites this paper
• On modeling and utilizing chemical compound information with deep learning technologies: A task-oriented approach

  2022cites this paper
• A Review of Computational Methods in Predicting hERG Channel Blockers

  2022cites this paper
• Ligand-based prediction of hERG-mediated cardiotoxicity based on the integration of different machine learning techniques

  2022cites this paper
• In silico pharmacokinetics, molecular docking and dynamic simulation studies of endolichenic fungi secondary metabolites: An implication in identifying novel kinase inhibitors as potential anticancer agents

  2022cites this paper
• Computer-aided analysis for identification of novel analogues of ketoprofen based on molecular docking, ADMET, drug-likeness and DFT studies for the treatment of inflammation

  2022cites this paper
• Machine Learning Toxicity Prediction: Latest Advances by Toxicity End Point

  2022cites this paper
• Investigating cardiotoxicity related with hERG channel blockers using molecular fingerprints and graph attention mechanism

  2022cites this paper
• Toward Quantitative Models in Safety Assessment: A Case Study to Show Impact of Dose–Response Inference on hERG Inhibition Models

  2022cites this paper
• Therapeutics Data Commons: Machine Learning Datasets and Tasks for Therapeutics

  2021cites this paper
• Artificial Intelligence, Big data and Machine Learning approaches in Preci-sion Medicine & Drug Discovery.

  2021cites this paper
• Novel QSAR approach for clearance prediction, combination DeepSnap-Deep Learning, and conventional machine learning

  2021cites this paper
• TSSF-hERG: A machine-learning-based hERG potassium channel-specific scoring function for chemical cardiotoxicity prediction.

  2021cites this paper
• The rise of deep learning and transformations in bioactivity prediction power of molecular modeling tools

  2021cites this paper
• Structure-Based Prediction of hERG-Related Cardiotoxicity: A Benchmark Study

  2021cites this paper
• Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development

  2021cites this paper
• Machine Learning Uncovers Adverse Drug Effects on Intestinal Bacteria

  2021cites this paper
• Automated and enabling technologies for medicinal chemistry.

  2021cites this paper
• Toxicity prediction based on artificial intelligence: A multidisciplinary overview

  2021cites this paper
• Virtual Screening of Pharmaceutical Compounds with hERG Inhibitory Activity (Cardiotoxicity) using Ensemble Learning

  2021cites this paper
• Reducing hERG Toxicity Using Reliable hERG Classification Model and Fragment Grow Model

  2020cites this paper
• Current status and future directions of high-throughput ADME screening in drug discovery

  2020cites this paper
• Capsule Networks Showed Excellent Performance in the Classification of hERG Blockers/Nonblockers

  2020cites this paper
• A Very Large-Scale Bioactivity Comparison of Deep Learning and Multiple Machine Learning Algorithms for Drug Discovery

  2020cites this paper
• Bioactivity Comparison across Multiple Machine Learning Algorithms Using over 5000 Datasets for Drug Discovery.

  2020influential citation
• Critical Assessment of Artificial Intelligence Methods for Prediction of hERG Channel Inhibition in the "Big Data" Era

  2020cites this paper
• Assessing hERG1 Blockade from Bayesian Machine-Learning-Optimized Site Identification by Ligand Competitive Saturation Simulations

  2020cites this paper
• Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.

  2020cites this paper
• Computational Approaches in Preclinical Studies on Drug Discovery and Development

  2020cites this paper
• Prediction of hERG potassium channel blockage using ensemble learning methods and molecular fingerprints.

  2020cites this paper
• Developing novel computational prediction models for assessing chemical-induced neurotoxicity using naïve Bayes classifier technique.

  2020cites this paper
• hERG-Att: Self-attention-based deep neural network for predicting hERG blockers

  2020cites this paper
• Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity

  2019influential citation
• DeepDock: Enhancing Ligand-protein Interaction Prediction by a Combination of Ligand and Structure Information

  2019cites this paper
• Bayesian machine learning to discover Bruton’s tyrosine kinase inhibitors

  2019cites this paper
• A drug-likeness toolbox facilitates ADMET study in drug discovery.

  2019cites this paper